Ending Eclampsia, September 2019 Exploring ways to integrate the two components of the Ending Eclampsia Model within existing training systems should be explored to further reduce costs. This implementation cost analysis serves as a starting point for those considering implementation…
Tag Archive for Bangladesh
Assessing the effect of a primary health care intervention for improving pre-eclampsia and eclampsia knowledge and practice in Bangladesh
Ending Eclampsia, 2019 This intervention, which targeted PHC facilities, has resulted in a number of notable successes. Results showed improved PHC provider knowledge, abilities, and practices for detecting, preventing, and managing PE/E, improved facility readiness to provide PE/E services, improved…
Hypertensive Disorders in Pregnancy: Assessing Postnatal Quality of Care and Outcomes for Women and Their Infants in Bangladesh
Ending Eclampsia, 2019 This gap analysis not only provides insights into the quality of care women with HDP received postnatally, as well as the outcomes for them and their infants, health statuses, and morbidity patterns, but will improve policy-makers’ and…
Autonomy, intimate partner violence, and maternal health-seeking behavior: Findings from mixed-methods analysis in Bangladesh
Ending Eclampsia, June 2019 Findings from quantitative and qualitative data suggest that gender dynamics, alongside other factors, affect women’s empowerment to seek maternal health services in Bangladesh. Download the brief for more information.
Hypertensive disorders of pregnancy: Risk factors and longterm complications
Ending Eclampsia, 2018 This graphic shares the risk factors and longterm complications of HDPs, including PE/E, for women and their babies. It also includes data from Ending Eclampsia’s five project countries – Bangladesh, Ethiopia, Kenya, Pakistan, and Nigeria – on…
Assessing quality of care and outcomes after pre-eclampsia/eclampsia
Ending Eclampsia, 2018 Study findings will inform policymakers for development of guidelines for managing women with hypertensive disorders in pregnancy during the postnatal period. The study may also benefit women if/when they require treatment and/or referral.
Feasibility of PHC providers prescribing antihypertensive drugs to pregnant women
Ending Eclampsia, 2018 The study will last 12 months and includes 20 to 25 facilities – approximately 50 providers – from two sub-districts, and enrolls 800 pregnant women with hypertension. Researchers anticipate understanding whether it is feasible for PHC providers…
Study: Introduction of antihypertensive drugs in selected upazilas in Bangladesh
By Kanij Sultana Every year in Bangladesh, between 5,000 and 6,000 women die from hypertensive disorders of pregnancy (HDP). Of those maternal deaths, between 1,000 and 1,200 are the result of undetected and unmonitored high blood pressure that progresses to…
Knowledge of Pre-eclampsia and Eclampsia in Bangladesh
Ending Eclampsia, 2017 Findings revealed barriers, including lack of awareness about signs and symptoms of PE/E, lack of access, financial hardship, and cultural norms cause delays in seeking timely care when pregnancy- and childbirth-related complications occur.
Policies for Pre-eclampsia and Eclampsia Prevention and Management
Ending Eclampsia, 2017 Findings revealed providers’ knowledge, attitudes, and practices of national policies, task sharing, proper use of MgSO4, detection and prevention measures, and use of the referral system. This brief includes recommendations for trainings and task sharing.
